16 completed, 6 unknown, 3 recruiting, 2 terminated. 5 Not applicable, 4 Phase 3, 4 Phase 4, 2 Phase 2.
Follow Anticoagulants and Bleeding Disorders: new trials by email Literature Review of Anticoagulants and Bleeding Disorders trials Research Report on Anticoagulants and Bleeding Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of Heparin Anti-Xa Activity From Central Venous Catheter Samples Using a 5 mL Syringe Flush or a Vacuum Tube Flush Versus Peripheral Vein Samples in ICU Patients catheter flushing techniques - Anticoagulants and Bleeding Disorders | Not applicable | Recruiting | Centre Hospitalier Régional d'Orléans | 30 | 2025-09-22 | 2025-11-25 |
| Prospective Observational Pilot Study of LMWH Versus UFH as ECMO Anticoagulation in Lung Transplantation Lung Transplantation, Extracorporeal Membrane Oxygenation (ECMO) | Recruiting | University Hospital, Motol | 40 | 2025-05-01 | 2025-06-10 | |
| Storytelling for Reducing Gap in Anticoagulation Use in African Americans With Atrial Fibrillation Storytelling Intervention - Atrial Fibrillation, Atrial Flutter | Not applicable | Enrolling by invitation | University of Massachusetts, Worcester | 80 | 2024-06-24 | 2026-04-13 |
| TRanEXamic Acid to Decrease Heavy Menstrual Bleeding in Individuals Anticoagulated for Venous Thromboembolism Pilot Study Tranexamic acid, No Tranexamic acid - Venous Thromboembolism, Venous Thromboses | Phase 4 | Unknown | University Health Network, Toronto | 20 | 2024-06-01 | 2024-06-12 |
| Safety of Anticoagulant Therapy After Tissue Glue for Gastric Varices Low molecular weight heparin - Anticoagulants and Bleeding Disorders, Tissue Adhesion | Unknown | Qilu Hospital of Shandong University | 100 | 2022-01-01 | 2022-09-19 | |
| Comparison of the Effect of Warfarin and Direct Oral Anticoagulants Anticoagulants and Bleeding Disorders, Gastrointestinal Hemorrhage | Completed | Samsun Education and Research Hospital | 346 | 2022-01-01 | 2024-02-21 | |
| Bleeding Oral Anticoagulant Analyzer (BOA) Quantra analyzer - Anticoagulants and Bleeding Disorders | Not applicable | Completed | University Hospital, Clermont-Ferrand | 80 | 2021-12-16 | 2024-02-07 |
| Safety and Feasibility of Argatroban As Anticoagulant in Adults with ECMO Argatroban, Unfractionated heparin - Extracorporeal Membrane Oxygenation Complication, Anticoagulants and Bleeding Disorders | Phase 2 / Phase 3 | Completed | Medical University of Vienna | 40 | 2021-12-01 | 2024-09-19 |
| Global Coagulation Assessment in Portal Vein Thrombosis and Budd-Chiari Syndrome Rotational thromboelastometry, Genetic tests for Thrombophilia, ELISA tests/ Functional assays - Hepatic Vein Thromboses, Hepatic Venous Outflow Obstruction | Unknown | Post Graduate Institute of Medical Education and Research, Chandigarh | 300 | 2021-10-15 | 2024-02-13 | |
| Nadroparin Pharmacokinetics in Different Stages of COVID-19 Nadroparin - Thrombosis, Nadroparin | Completed | Medical University of Lublin | 43 | 2021-02-01 | 2022-11-18 | |
| Left Atrial Appendage Occlusion for AF Patients Unable to Use Oral Anticoagulation Therapy Left atrial appendage occlusion (Watchman FLX or Amplatzer Amulet) - Atrial Fibrillation, Anticoagulants and Bleeding Disorders | Not applicable | Active not recruiting | R&D Cardiologie | 609 | 2021-01-01 | 2024-06-21 |
| Coagulation and Vitamin K in Head and Neck Microvascular Free Flap Surgery Head and Neck Cancer, Intraoperative Complications | Completed | Region Skane | 40 | 2020-09-15 | 2024-02-29 | |
| A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to (SARS-CoV-2) COVID-19 Pandemic Therapeutic anticoagulation - COVID, Coronavirus Infection | Phase 3 | Completed | University of Sao Paulo General Hospital | 465 | 2020-07-04 | 2021-10-26 |
| Evaluating Dose Regimen of Intravenous Unfractionated Heparin and Low Molecular Weight Heparin in Critical Ill Patients Versus Critical Ill COVID-19 Patients Using Anti-Xa Levels. Enoxaparin, Heparin - COVID-19, Deep Vein Thrombosis | Completed | University Hospital, Ghent | 813 | 2020-01-01 | 2023-05-11 | |
| A Prospective Study in Chinese Patients With Lower Extremity Ankle Fracture of Oral Anticoagulants to Prevent Venous Thromboembolism (VTE) Apixaban Oral Tablet - Foot Ankle Injuries, Anticoagulants and Bleeding Disorders | Phase 4 | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 1000 | 2020-01-01 | 2019-11-19 |
| Bivalirudin in Elderly Patients Undergoing Elective Percutaneous Coronary Intervention. Bivalirudin, Heparin - Acute Coronary Syndrome, Percutaneous Coronary Intervention | Phase 4 | Unknown | The First Affiliated Hospital of Dalian Medical University | 240 | 2019-07-08 | 2019-08-06 |
| Evaluating LumiraDx INR Test Accuracy in Patients Taking Phenprocoumon Anticoagulant. Venous and Fingerstick blood draws, Venous blood draw - Anticoagulants and Bleeding Disorders | Completed | LumiraDx UK Limited | 102 | 2019-05-09 | 2026-06-12 | |
| MAC Project, Monitoring of AntiCoagulant Therapies (MAC) Anticoagulant drugs - Anticoagulants and Bleeding Disorders | Completed | Quovadis Associazione | 2000 | 2019-03-01 | 2025-05-07 | |
| Anticoagulation and Antiplatelet Management During Perioperative Period Anticoagulants and Bleeding Disorders | Completed | Erasme University Hospital | 2400 | 2019-01-01 | 2020-08-12 | |
| Rivaroxaban vs Warfarin in Patients With Metallic Prosthesis Rivaroxaban 15 mg, Warfarin - Prostheses and Implants, Stroke | Phase 2 / Phase 3 | Terminated | Hospital Geral Roberto Santos | 50 | 2018-07-10 | 2020-05-15 |
Showing 20 of 29. Sign in to see all of them.
Hemostatic Disorders (29) · Atrial Fibrillation (4) · Venous Thromboembolism (4) · Hemorrhage (3) · Stroke (3) · Thrombosis (3) · COVID-19 (2) · Venous Thrombosis (2) · Acute Coronary Syndrome (1) · Atrial Flutter (1) · Blood Coagulation Disorders (1) · Budd-Chiari Syndrome (1) · Coronavirus Infections (1) · Critical Illness (1) · Emergencies (1)
Cardiovascular Diseases (29) · Hematologic Diseases (29) · Hemic and Lymphatic Diseases (29) · Hemorrhagic Disorders (29) · Vascular Diseases (29) · Pathologic Processes (11) · Pathological Conditions, Signs and Symptoms (11) · Embolism and Thrombosis (9) · Heart Diseases (6) · Arrhythmias, Cardiac (4) · Thromboembolism (4) · Brain Diseases (3) · Central Nervous System Diseases (3) · Cerebrovascular Disorders (3) · Coronaviridae Infections (3)
Warfarin (5) · Enoxaparin (3) · Heparin (3) · apixaban (3) · Anticoagulants (2) · Nadroparin (2) · Rivaroxaban (2) · edoxaban (2) · Blood Specimen Collection (1) · Dabigatran (1) · Genetic Testing (1) · Heparin, Low-Molecular-Weight (1) · Tranexamic Acid (1) · acarboxyprothrombin (1) · argatroban (1)
Salem Anaesthesia Pain Clinic (2) · Centre Hospitalier Régional d'Orléans (1) · Erasme University Hospital (1) · Hadassah Medical Organization (1) · Hospital Geral Roberto Santos (1) · LumiraDx UK Limited (1) · Medical University of Lublin (1) · Medical University of Vienna (1) · Post Graduate Institute of Medical Education and Research, Chandigarh (1) · Qilu Hospital of Shandong University (1) · Quovadis Associazione (1) · R&D Cardiologie (1) · Region Skane (1) · Samsun Education and Research Hospital (1) · Samsung Medical Center (1)
China (3) · United States (3) · Belgium (2) · Brazil (2) · Canada (2) · France (2) · Italy (2) · Austria (1) · Czechia (1) · Germany (1) · India (1) · Israel (1) · Netherlands (1) · Poland (1) · Serbia (1)
Olu Bamgbade, MD,FRCPC (2) · Alok Kapoor, MD (1) · Andre Duraes, PhD (1) · Branislav Bajkin, PhD (1) · Caroline U Nilsson, MD, PhD (1) · Cristiano Bortoluzzi, MD (1) · Daryl S Henshaw, MD (1) · Dong Seop Jeong, PhD (1) · Dorian Teissandier (1) · Elnara M Negri, MD, PhD (1) · Harlinde Peperstraete, MD (1) · Hassan Rahhal, MD (1) · Heinz Voller (1)
PMID 28492441, PMID 30293126, PMID 31735436, PMID 33150497, PMID 34268513, PMID 35537503, PMID 37097604, PMID 37280083, PMID 38580558
R21MD017646 (1)